Cancer Therapy & Research Center at UTHSCSA

癌症治疗

基本信息

批准号：
7917180
负责人：
IAN M. THOMPSON
金额：
$ 12.68万
依托单位：
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
起止时间：
1997-08-01 至 2012-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7917180
关键词：
Address Administrator Advanced Malignant Neoplasm Advisory Committees Aging Allied Health Sciences Animal Model Antibodies Antibody Formation Applications Grants Appointment Area Attention Award Basic Science Biological Sciences Biomedical Research Biometry Biotechnology Blood Pressure Budgets Calendar Cancer Biology Cancer Center Cancer Center Support Grant Cancer Grant Supplements (P30)Cancer Patient Cancer Research Infrastructure Caring Catchment Area Characteristics Charge Child Chronic Clinic Clinical Clinical Protocols Clinical Research Clinical Trials Clinical and Translational Science Awards Collaborations Colon Carcinoma Communities Community Outreach Contracts Country County Critiques DNA Double Strand Break Data Databases Decision Making Dental Schools Development Developmental Therapeutics Program Diagnosis Direct Costs Disadvantaged Discipline Disease Doctor of Philosophy Education Effectiveness Electronic Mail Elements Endowment Enrollment Ensure Epidemiology Equipment Evaluation Facilities and Administrative Costs Faculty Female Breast Carcinoma Female breast Flow Cytometry Fostering Foundations Funding Future Genetic Genetic Variation Genomics Geographic Locations Gifts Goals Grant Growth Guidelines Health Health Insurance Health Occupations Health Promotion Health Sciences Health system Healthcare Heart Hematology Heterogeneity Hispanics Hormones Human Genome Image Incidence Individual Industry Inflammation Informatics Institutes Institution Insurance Coverage Investments Leadership Link Lung Malignant Neoplasms Malignant neoplasm of lung Malignant neoplasm of prostate Mass Spectrum Analysis Medical Medical Education Medical Oncology Medical Research Medical center Minority Mission Molecular Molecular Structure Monitor Names National Cancer Institute Obesity Organization and Administration Outcome Parents Pathology Patient Care Patient-Centered Care Patients Pattern Pediatric Oncology Peer Review Peer Review Grants Pennsylvania Pharmaceutical Preparations Pharmacy facility Phase Pilot Projects Policies Population Population Research Population Sciences Population Study Positioning Attribute Postdoctoral Fellow Predisposition Prevention Process Prostate Protocols documentation Public Health Public Health Schools Published Comment Radiation Oncology Recommendation Recording of previous events Recruitment Activity Reporting Research Research Infrastructure Research Institute Research Personnel Resistance Resource Sharing Resources Review Committee Role Safety San Antonio Cancer Institute School Nursing Schools Science Scientist Screening for cancer Services Site Visit Source South Texas Stress Structure Students Suggestion Sum System Texas Text The Sun Therapeutic Therapeutic Studies Time Training Translating Translational Research Trust Tumor Immunity United States National Institutes of Health Universities Update Urogenital Cancer Vertebrates Weight Woman Work Writing age related anticancer research austin base cancer prevention cancer research center director cancer therapy cost cost effectiveness data sharing design disorder risk drug development experience genetic association genome wide association study health disparity hormone resistance host neoplasm interaction human subject human subject protection implementation research insight instrumentation interdisciplinary collaboration interest low socioeconomic status malignant breast neoplasm medical schools meetings member novel nutrition oncology optical imaging outreach patient safety population based prevent professor programs ranpirnase repaired repository research study response socioeconomics square foot trait treatment strategy tumor tumor immunology

项目摘要

DESCRIPTION (provided by applicant): This application is to renew the NCI Cancer Center P30 Support Grant for the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio (UTHSCSA) for years 17-21. The CTRC at UTHSCSA merged with the formerly-independent CTRC to form this new entity (hereinafter called "CTRC"). This merger, in the form of a $150 million gift, the largest gift in UTHSCSA history, and among the largest in University of Texas history, brings full alignment to our Cancer Center activities. With this merger and realignment, the CTRC has re-entered a period of significant growth and improvement in the quality of its clinical, basic, translational and population-based research programs. Our NCI funding base has increased from $8,453,756 in 2006 to $11,050,146 in 2007. We serve a vast geographic region in and around San Antonio and South Texas, larger than the state of Pennsylvania and comprising 4.4 million inhabitants. Our population is predominantly Hispanic and dominated by individuals in lower socioeconomic strata with the lowest rates of health insurance coverage in the nation. We have worked to serve the disadvantaged for years, and are now also re-focusing more research and clinical efforts to understand better the specific cancer-related risks and disease patterns in Hispanics, and to serve the needs of our citizens better. We have significant community outreach, wellness and cancer screening programs reaching these disadvantaged populations. These efforts are greatly helped in that leaders in our Cancer Center and at UTHSCSA are Hispanic. We request support for three research programs, ten shared resources, seven senior leaders, one staff investigator, modest developmental funds, and commensurate administrative support. Our three research programs are Cancer Prevention and Population Sciences, Experimental and Developmental Therapeutics, and Cancer Development and Progression. Our shared resources are Antibody, Biostatistics and Informatics, Flow Cytometry, Genomics, Macromolecular Interactions, Macromolecular Structure, Mass Spectrometry, Optical Imaging, Pathology, and Research Administration. The CTRC will continue its record of promoting inter-programmatic and intra-programmatic collaborations, and strategic use of developmental funds, in combination with significant institutional commitment and a successful record of philanthropic support that in sum ensures a synergistic return on investment not possible without the P30 infrastructure and guidance.

描述（由申请人提供）：本申请旨在将 NCI 癌症中心 P30 支持补助金延长至圣安东尼奥德克萨斯大学健康科学中心 (UTHSCSA) 癌症治疗和研究中心 (CTRC) 的 17-21 年。 UTHSCA 的 CTRC 与以前独立的 CTRC 合并，形成这个新实体（以下简称“CTRC”）。此次合并以 1.5 亿美元的捐赠形式进行，这是 UTHSCSA 历史上最大的捐赠，也是德克萨斯大学历史上最大的捐赠之一，使我们的癌症中心活动完全一致。通过这次合并和重组，CTRC 重新进入了其临床、基础、转化和基于人群的研究项目质量显着增长和提高的时期。我们的 NCI 资金基础已从 2006 年的 8,453,756 美元增加到 2007 年的 11,050,146 美元。我们为圣安东尼奥和德克萨斯州南部及其周边地区的广大地理区域提供服务，该区域比宾夕法尼亚州还要大，拥有 440 万居民。我们的人口主要是西班牙裔，以社会经济较低阶层的人为主，他们的健康保险覆盖率是全国最低的。多年来，我们一直致力于为弱势群体服务，现在也重新集中更多的研究和临床工作，以更好地了解西班牙裔特定的癌症相关风险和疾病模式，并更好地满足我们公民的需求。我们有重要的社区外展、健康和癌症筛查计划来帮助这些弱势群体。这些努力得到了极大的帮助，因为我们的癌症中心和 UTHSCSA 的领导者都是西班牙裔。我们请求支持三个研究项目、十个共享资源、七名高级领导、一名研究员、适度的发展资金和相应的行政支持。我们的三个研究项目是癌症预防和人口科学、实验和发育治疗学以及癌症的发展和进展。我们的共享资源包括抗体、生物统计学和信息学、流式细胞术、基因组学、大分子相互作用、大分子结构、质谱分析、光学成像、病理学和研究管理。 CTRC 将继续其促进计划间和计划内合作以及发展资金的战略使用的记录，并结合重大的机构承诺和慈善支持的成功记录，总而言之，如果没有P30 基础设施和指导。